PubRank

S M Corsello

Author PubWeight™ 17.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome. Clin Endocrinol (Oxf) 2000 1.17
2 Intracranial and spinal dissemination of an ACTH secreting pituitary neoplasia. Case report and review of the literature. Ann Endocrinol (Paris) 1997 0.93
3 Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study. J Endocrinol Invest 2006 0.90
4 Prolactin secretion after beer. Lancet 1981 0.89
5 Pseudotumor cerebri as presenting syndrome of Addisonian crisis. Ital J Neurol Sci 1995 0.89
6 Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer. J Nucl Med 1998 0.89
7 Reversible dilated cardiomyopathy due to growth hormone deficiency. Chest 1992 0.88
8 The treatment of neuroendocrine tumors with long-acting somatostatin analogs: a single center experience with lanreotide autogel. J Endocrinol Invest 2011 0.86
9 Thyrotoxicosis due to ectopic retrotracheal adenoma treated with radioiodine. J Nucl Biol Med 1993 0.85
10 Postpartum thyroiditis presenting as a cold nodule and evolving to Graves' disease. Int J Clin Pract 2003 0.82
11 [Preoperative and postoperative management of adrenal masses]. G Chir 2010 0.82
12 Medullary thyroid cancer: a promising model for targeted therapy. Curr Mol Med 2010 0.82
13 Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade. J Clin Endocrinol Metab 1989 0.80
14 Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man. J Clin Endocrinol Metab 1990 0.80
15 Thyroid scintigraphy: an old tool is still the gold standard for an effective diagnosis of autonomously functioning thyroid nodules. J Endocrinol Invest 2012 0.79
16 Levothyroxine therapy in preventing nodular recurrence after hemithyroidectomy: a retrospective study. J Endocrinol Invest 2009 0.77
17 Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans. J Clin Endocrinol Metab 1991 0.77
18 Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series. Minerva Endocrinol 2013 0.77
19 Thyroid function in altered nutritional state. Exp Clin Endocrinol 1983 0.76
20 Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle. Metabolism 1989 0.76
21 Endocrine study of anorexia nervosa. Exp Clin Endocrinol 1983 0.76
22 Autoimmune polyglandular syndrome, primary empty sella, and acute lymphocytic leukaemia. Clin Endocrinol (Oxf) 1987 0.76
23 A clinical study of Addison's disease. Exp Clin Endocrinol 1987 0.75
24 [Amiodarone and thyroid function]. Clin Ter 1987 0.75
25 Treatment of undescended testes with hMG and hMG plus hCG: clinical, hormonal and sonographic evaluation. Ann Endocrinol (Paris) 1987 0.75
26 Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics. Metabolism 1992 0.75
27 Failure of bromocriptine to modify the response to metyrapone in normal subjects. Ann Endocrinol (Paris) 1981 0.75
28 Effect of estrogens on luteinizing hormone release in testicular feminization syndrome before and after gonadectomy. Obstet Gynecol 1984 0.75
29 [Evaluation of the testicular function using the HCG test in normal and cryptorchid children]. Pediatr Med Chir 1988 0.75
30 Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor. Q J Nucl Med 1995 0.75
31 [Amiodarone-induced thyroid pathology]. Clin Ter 1987 0.75
32 [Contribution of nuclear medicine to the diagnosis of silent adrenal masses]. Radiol Med 1994 0.75
33 Effect of somatostatin on the pituitary-thyroid axis. Ann Endocrinol (Paris) 1983 0.75
34 Detection of an intrathymic parathyroid adenoma by Tc-99m tetrofosmin: a comparison with Tl-201. Clin Nucl Med 1996 0.75
35 Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity. Neuroendocrinology 1989 0.75
36 Dexamethasone inhibition of interferon-alpha 2-induced stimulation of cortisol and growth hormone secretion in chronic myeloproliferative syndrome. J Clin Endocrinol Metab 1995 0.75
37 Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine. Eur J Nucl Med 1984 0.75
38 Peripheral neuropathy and 46XY gonadal dysgenesis: confirmation of a heterogeneous entity. Clin Neurol Neurosurg 2011 0.75
39 Long-term effects of radiotherapy for acromegaly on circulating prolactin. Acta Endocrinol (Copenh) 1989 0.75
40 [Amiodarone]. Ann Ital Med Int 1990 0.75
41 [The management of thyrotoxicosis: a schematic approach]. Minerva Endocrinol 2002 0.75
42 [The role of phospholipids in the bioavailability of an adrenal cortex extract]. Clin Ter 1982 0.75